Line Aagaard Nolting, MD (she/her/hers)

Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark

Disclosure information not submitted.

Presentation(s):

• ORF47-06 - Navepegritide Combined with Lonapegsomatropin for the Treatment of Achondroplasia: An Open-Label Phase 2 Trial

  Monday, June 15, 2026
  2:30 PM - 2:45 PM CT